ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,641, issued on March 3, was assigned to Codexis Inc. (Redwood City, Calif.).
"Engineered terminal deoxynucleotidyl transferase variants" was invented by Charlene Ching (San Jose, Calif.), Stephanie Marie Forget (Redwood City, Calif.), Anders Matthew Knight (Mountain View, Calif.), Mikayla Jianghongxia Krawczyk (Palo Alto, Calif.), Niusha Mahmoodi (San Francisco), Melissa Ann Mayo (Foster City, Calif.), Mathew G. Miller (San Carlos, Calif.) and Jonathan Vroom (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides engineered terminal deoxynucleotidyl transferase (TdT) polypeptides useful in template-...